Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 52

Sort by

Sort Order Select

Journal Articles

Increased Frequency of Mosaic Chromosomal Alterations in Peripheral Blood Samples of Sub-Saharan African Children with Endemic Burkitt Lymphoma

Blood (2022) 140 (Supplement 1): 9240–9241.

https://doi.org/10.1182/blood-2022-169500

Published: 2022

Journal Articles

Comparison of Gold Standard Genescan with NGS-Based TCR-Beta Clonality Analysis Using Oncomine TCR Beta-Short Read Assay

Cora Husemann, Karsten Kleo, Timothy Looney, PhD, Chris Allen, Bernhard Josef Woermann, Markus Möbs, Michael Hummel

Blood (2019) 134 (Supplement_1): 4664.

https://doi.org/10.1182/blood-2019-129822

Published: 2019

Journal Articles

Senescence Markers from a DLBCL-Reminiscent Mouse Lymphoma Model Predict Patient Outcome

Kolja Schleich, Julia Kase, MD, Jan R. Dörr, Saskia Trescher, Animesh Battacharya, Yong Yu, Philipp Lohneis, MD, Dido Lenze, Dorothy Ngo-Yin Fan, Michael Hummel, PhD, Ulf Leser, Clemens A. Schmitt

Blood (2018) 132 (Supplement 1): 2850.

https://doi.org/10.1182/blood-2018-99-118002

Published: 2018

Journal Articles

Mouse Lymphoma Model-Based Senescence Exploitation to Predict Treatment Outcome of DLBCL Patients

Kolja Schleich, PhD, Julia Kase, MD, Jan R. Dörr, Saskia Trescher, Animesh Battacharya, Yong Yu, Philipp Lohneis, MD, Dido Lenze, Dorothy Ngo-Yin Fan, Michael Hummel, PhD, Ulf Leser, Clemens A. Schmitt

Blood (2017) 130 (Supplement 1): 5133.

https://doi.org/10.1182/blood.V130.Suppl_1.5133.5133

Published: 2017

Journal Articles

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Blood (2017) 129 (1): 71–81.

https://doi.org/10.1182/blood-2016-02-700773

Published: 2017

Includes: Supplemental data

Journal Articles

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

Larry Mansouri, Daniel Noerenberg, Emma Young, Elena Mylonas, Maysaa Abdulla, Mareike Frick, Fazila Asmar, Viktor Ljungström, Markus Schneider, Kenichi Yoshida, Aron Skaftason, Tatjana Pandzic, Blanca Gonzalez, Anna Tasidou, Nils Waldhueter, Alfredo Rivas-Delgado, Maria Angelopoulou, Marita Ziepert, Christopher Maximilian Arends, Lucile Couronné, Dido Lenze, Claudia D. Baldus, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga D. Munch-Petersen, Thorsten Zenz, Martin-Leo Hansmann, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Martin Erlanson, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Seishi Ogawa, Ralf Küppers, Kostas Stamatopoulos, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, Elias Campo, Rose-Marie Amini, German Ott, Theodoros P. Vassilakopoulos, Michael Hummel, Richard Rosenquist, Frederik Damm

Blood (2016) 128 (23): 2666–2670.

https://doi.org/10.1182/blood-2016-03-704528

Published: 2016

Includes: Supplemental data

Journal Articles

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

Blood (2016) 128 (22): 151.

https://doi.org/10.1182/blood.V128.22.151.151

Published: 2016

Journal Articles

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Daniel Noerenberg*, Larry Mansouri*, Emma Young, Frick Mareike, Maysaa Abdulla, Fazila Asmar, Blanca Gonzalez-Farre, Tasidou Anna, Nils Waldhueter, Viktor Ljungström, Alfredo Rivas, Maria K. Angelopoulou, Marita Ziepert, Christopher M. Arends, Lucile Couronne, Dido Lenze, Claudia D. Baldus, MD, Christian Bastard, Jessica Okosun, Jude Fitzgibbon, Bernd Dörken, Hans G. Drexler, Damien Roos-Weil, Clemens A. Schmitt, Helga Duverger Munch-Petersen, Thorsten Zenz, Jonathan C. Strefford, Gunilla Enblad, Olivier A. Bernard, Elisabeth Ralfkiaer, Penelope Korkolopoulou, Magnus Hultdin, Theodora Papadaki, Kirsten Grønbæk, Armando Lopez-Guillermo, Kostas Stamatopoulos, MD PhD, Niki Stavroyianni, George Kanellis, Andreas Rosenwald, MD, Elias Campo, Rose-Marie Amini, German Ott, Theodoros Vassilakopoulos, Michael Hummel, Frederik Damm**, Richard Rosenquist**

Blood (2016) 128 (22): 609.

https://doi.org/10.1182/blood.V128.22.609.609

Published: 2016

Journal Articles

Adoptive Transfer of CMV- and EBV- Specific Peptide-Stimulated T Cells after Allogeneic Stem Cell Transplantation: First Results of a Phase I/IIa Clinical Trial [Multivir-01]

Regina Gary, Michael Aigner, Andreas Moosmann, Julia Ritter, Volkhard Seitz, Stephanie Moi, Stefanie Schaffer, Heidi Balzer, Stefanie Maas, MD, Julian Strobel, MD, Robert Zimmermann, Juergen Zingsem, Anita Kremer, Steffen Hennig, Michael Hummel, Andreas Mackensen, Armin Gerbitz

Blood (2016) 128 (22): 2179.

https://doi.org/10.1182/blood.V128.22.2179.2179

Published: 2016

Journal Articles

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Blood (2015) 126 (23): 3875.

https://doi.org/10.1182/blood.V126.23.3875.3875

Published: 2015

Journal Articles

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Blood (2015) 125 (1): 124–132.

https://doi.org/10.1182/blood-2014-08-594507

Published: 2015

Includes: Supplemental data

Journal Articles

Abnormally differentiated CD4 + or CD8 + T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency

Blood (2014) 124 (6): 851–860.

https://doi.org/10.1182/blood-2014-03-564286

Published: 2014

Includes: Supplemental data

Journal Articles

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

Blood (2014) 123 (8): 1187–1198.

https://doi.org/10.1182/blood-2013-06-507996

Published: 2014

Includes: Supplemental data

Journal Articles

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

Sylvia Hartmann, Dennis A. Eichenauer, Annette Plütschow, Anja Mottok, Roshanak Bob, Karoline Koch, Heinz-Wolfram Bernd, Sergio Cogliatti, Michael Hummel, Alfred C. Feller, German Ott, Peter Möller, Andreas Rosenwald, Harald Stein, Martin-Leo Hansmann, Andreas Engert, Wolfram Klapper

Blood (2013) 122 (26): 4246–4252.

https://doi.org/10.1182/blood-2013-07-515825

Published: 2013

Includes: Supplemental data

Journal Articles

In-Depth miRNA Profiling Of Germinal Center Derived B-Cell Lymphomas By Next Generation Sequencing: A Report From The German Icgc-Mmml-Seq Project

Jessica I Hoell, MD, Kebria Hezaveh, Stephan Bernhart, Steve Hoffmann, David Langenberger, Matthias Schlesner, Peter Stadler, Vera Binder, Dido Lenze, Reiner Siebert, MD, Michael Hummel, PhD, Arndt Borkhardt, MD

Blood (2013) 122 (21): 2500.

https://doi.org/10.1182/blood.V122.21.2500.2500

Published: 2013

Journal Articles

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

Blood (2013) 122 (21): 4262.

https://doi.org/10.1182/blood.V122.21.4262.4262

Published: 2013

Journal Articles

Acquired Stem Cell Properties In Therapy-Induced Senescence Of Lymphomas and Acute Leukemias In Vitro and In Vivo

J. Henry M. Däbritz, Maja Milanovic, PhD, Zhen Zhao, MD, PhD, Jan R. Dörr, Yong Yu, Dido Lenze, PhD, Bernd Dörken, Michael Hummel, PhD, Christoph Dieterich, PhD, Scott W. Lowe, PhD, Clemens A. Schmitt, MD

Blood (2013) 122 (21): 4193.

https://doi.org/10.1182/blood.V122.21.4193.4193

Published: 2013

Journal Articles

IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL

Blood (2013) 122 (13): 2242–2250.

https://doi.org/10.1182/blood-2013-06-508028

Published: 2013

Includes: Supplemental data

Journal Articles

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Blood (2013) 121 (12): 2253–2263.

https://doi.org/10.1182/blood-2012-06-435842

Published: 2013

Journal Articles

Cross-Species Investigations Reveal Role, Mechanism and Predictive Power of Paracrine, Secondary Senescence in B-Cell Lymphoma Therapy

Jan R. Dörr, Maja Milanovic, Yong Yu, Julia Kase, Dido Lenze, Michael Hummel, Gunnar Dittmar, Bernd Dörken, Georg Lenz, Soyoung Lee, Clemens A Schmitt

Blood (2012) 120 (21): 3715.

https://doi.org/10.1182/blood.V120.21.3715.3715

Published: 2012

NARROW

Increased Frequency of Mosaic Chromosomal Alterations in Peripheral Blood Samples of Sub-Saharan African Children with Endemic Burkitt Lymphoma

Comparison of Gold Standard Genescan with NGS-Based TCR-Beta Clonality Analysis Using Oncomine TCR Beta-Short Read Assay

Senescence Markers from a DLBCL-Reminiscent Mouse Lymphoma Model Predict Patient Outcome

Mouse Lymphoma Model-Based Senescence Exploitation to Predict Treatment Outcome of DLBCL Patients

Pharmacological restoration and therapeutic targeting of the B-cell phenotype in classical Hodgkin lymphoma

Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma

The Clinical Impact of the Cell-of-Origin Classification and the MYC+/BCL2+ Double Expresser Status in DLBCL Treated within Prospective Clinical Trials of the Dshnhl

ΝFΚΒΙΕ Deletions : A Novel Marker of Clinical Aggressiveness in Primary Mediastinal B-Cell Lymphoma

Adoptive Transfer of CMV- and EBV- Specific Peptide-Stimulated T Cells after Allogeneic Stem Cell Transplantation: First Results of a Phase I/IIa Clinical Trial [Multivir-01]

Identification of Blut, a Novel Long-Noncoding RNA Differentially Expressed in Burkitt Lymphoma

Essential role of IRF4 and MYC signaling for survival of anaplastic large cell lymphoma

Abnormally differentiated CD4 + or CD8 + T cells with phenotypic and genetic features of double negative T cells in human Fas deficiency

A recurrent 11q aberration pattern characterizes a subset of MYC -negative high-grade B-cell lymphomas resembling Burkitt lymphoma

The prognostic impact of variant histology in nodular lymphocyte-predominant Hodgkin lymphoma: a report from the German Hodgkin Study Group (GHSG)

In-Depth miRNA Profiling Of Germinal Center Derived B-Cell Lymphomas By Next Generation Sequencing: A Report From The German Icgc-Mmml-Seq Project

The Prognostic Impact Of Gene Rearrangements and Protein Expression Of MYC, BCL2 and BCL6 In Young High-Risk Patients With DLBCL

Acquired Stem Cell Properties In Therapy-Induced Senescence Of Lymphomas and Acute Leukemias In Vitro and In Vivo

IκB-ζ controls the constitutive NF-κB target gene network and survival of ABC DLBCL

MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

Cross-Species Investigations Reveal Role, Mechanism and Predictive Power of Paracrine, Secondary Senescence in B-Cell Lymphoma Therapy

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only